HighTower Advisors’s iBio IBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-554
Closed -$3K 3729
2023
Q3
$3K Sell
554
-46
-8% -$398 ﹤0.01% 3449
2023
Q2
$8K Hold
600
﹤0.01% 3317
2023
Q1
$25K Buy
+600
New +$15.4K ﹤0.01% 3127
2021
Q4
Sell
-21
Closed -$11K 3377
2021
Q3
$11K Sell
21
-4
-16% -$2.49K ﹤0.01% 3030
2021
Q2
$18K Buy
25
+4
+19% +$2.92K ﹤0.01% 2961
2021
Q1
$15K Buy
21
+1
+5% +$871 ﹤0.01% 2916
2020
Q4
$11K Hold
20
﹤0.01% 2510
2020
Q3
$20K Buy
+20
New +$29K ﹤0.01% 2371
2020
Q1
Sell
-20
Closed -$2K 2358
2019
Q4
$2K Hold
20
﹤0.01% 2250
2019
Q3
$5K Hold
20
﹤0.01% 2337
2019
Q2
$7K Hold
20
﹤0.01% 2302
2019
Q1
$9K Hold
20
﹤0.01% 2208
2018
Q4
$8K Sell
20
-7
-26% -$2.71K ﹤0.01% 2129
2018
Q3
$12K Hold
27
﹤0.01% 2195
2018
Q2
$12K Hold
27
﹤0.01% 2131
2018
Q1
$30K Hold
27
﹤0.01% 2046
2017
Q4
$24K Hold
27
﹤0.01% 2148
2017
Q3
$43K Hold
27
﹤0.01% 2095
2017
Q2
$53K Buy
27
+2
+8% +$3.92K ﹤0.01% 2027
2017
Q1
$54K Buy
25
+2
+9% +$4.16K ﹤0.01% 1914
2016
Q4
$45K Hold
23
﹤0.01% 1823
2016
Q3
$62K Hold
23
﹤0.01% 1770
2016
Q2
$81K Buy
+23
New +$75.1K ﹤0.01% 1613

Other funds holding IBIO

HighTower Advisors's IBIO Position: Q4 2023 in Review

HighTower Advisors sold out of iBio (IBIO) in Q4 2023, closing a stake of 554 shares — an estimated $3K sold.

HighTower Advisors first reported a position in IBIO in Q2 2016 and held it in 23 quarters. The position peaked at $81K in Q2 2016. 21 funds tracked by Wall St. Rank hold IBIO as of Q4 2023.

  • HighTower Advisors reported no remaining iBio position as of Q4 2023 after selling out during the quarter.
  • HighTower Advisors sold 554 iBio shares in Q4 2023, an estimated $3K.
  • HighTower Advisors first reported a position in iBio in Q2 2016 and held it in 23 quarters.
  • HighTower Advisors's iBio position peaked at $81K in Q2 2016.
  • 21 funds tracked by Wall St. Rank held iBio as of Q4 2023.

Based on HighTower Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.